Rui-da Quan

CMAR_A_190332 2565..2578

Xiao-Hua Zhang, Er-jie Xia, C. Zheng, 2019 .

CMAR_A_270385 8875..8886

Xuanxuan Dai, C. Zheng, Xiaohua Zhang, 2020 .

Original tumour suppressor gene polycystic kidney and hepatic disease 1-like 1 is associated with thyroid cancer cell progression

Xiaohua Zhang, C. Zheng, Adheesh Bhandari, 2019, Oncology letters.

COPB2 is up‐regulated in breast cancer and plays a vital role in the metastasis via N‐cadherin and Vimentin

O. Wang, C. Zheng, Adheesh Bhandari, 2019, Journal of cellular and molecular medicine.

NECTIN4 promotes papillary thyroid cancer cell proliferation, migration, and invasion and triggers EMT by activating AKT

C. Zheng, Xiaojiao Zhou, R. Hao, 2019, Cancer management and research.

The Prognostic Value of Combination of Plasma Fibrinogen and CA19-9 in Non-Distant Metastatic Breast Cancer Patients Undergoing Surgery

Xiaohua Zhang, Xuanxuan Dai, C. Zheng, 2020, Cancer management and research.

Lysophosphatidic Acid Receptor 5 (LPAR5) Plays a Significance Role in Papillary Thyroid Cancer via Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (mTOR) Pathway

C. Zheng, R. Hao, Chen-Yong Wu, 2020, Medical science monitor : international medical journal of experimental and clinical research.

LOC389641 promotes papillary thyroid cancer progression by regulating the EMT pathway.

C. Zheng, Jialiang Wen, J. Qu, 2020, Biomarkers in medicine.

Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial‐mesenchymal transition

O. Wang, C. Zheng, Adheesh Bhandari, 2020, Cell biochemistry and function.

Growth‐associated protein 43 promotes thyroid cancer cell lines progression via epithelial‐mesenchymal transition

O. Wang, Xubin Dong, C. Zheng, 2019, Journal of cellular and molecular medicine.

Low metallothionein 1M (MT1M) is associated with thyroid cancer cell lines progression.

Yizuo Chen, L. Teng, J. You, 2019, American journal of translational research.